Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatments and Outcomes in Patients With Primary Cutaneous Lymphoma: a Nationwide Multi-center Prospective Study in China

NCT05518851 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT05518851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05518851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatments and Outcomes in Patients With Primary Cutaneous Lymphoma: a Nationwide Multi-center Prospective Study in China
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2022
Completion date
August 31, 2032
Enrollment
3,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

primary cutaneous lymphoma